cetirizine has been researched along with Eosinophilia in 20 studies
Cetirizine: A potent second-generation histamine H1 antagonist that is effective in the treatment of allergic rhinitis, chronic urticaria, and pollen-induced asthma. Unlike many traditional antihistamines, it does not cause drowsiness or anticholinergic side effects.
cetirizine : A member of the class of piperazines that is piperazine in which the hydrogens attached to nitrogen are replaced by a (4-chlorophenyl)(phenyl)methyl and a 2-(carboxymethoxy)ethyl group respectively.
Eosinophilia: Abnormal increase of EOSINOPHILS in the blood, tissues or organs.
| Excerpt | Relevance | Reference |
|---|---|---|
| " However, systemic agents that are safe for long-term use are required for patients with widespread or resistant lesions." | 5.51 | Eosinophilic pustular folliculitis of infancy suppressed with cetirizine. ( Demirsoy, U; Kiran, R; Odyakmaz Demirsoy, E; Ozod, U, 2019) |
| "To further elucidate the anti-inflammatory properties of cetirizine, we first examined its effects on antigen-induced eosinophilia and neutrophila in vivo." | 3.72 | Cetirizine, an H1-receptor antagonist, suppresses the expression of macrophage migration inhibitory factor: its potential anti-inflammatory action. ( Abe, R; Ishibashi, T; Nishihira, J; Shimizu, H; Shimizu, T; Watanabe, H, 2004) |
| "Cetirizine was significantly more effective at reducing the mean rhinorrhea score compared with oxatomide for both weeks 8 and 12 (P < 0." | 2.70 | The comparison of the efficacy and safety of cetirizine, oxatomide, ketotifen, and a placebo for the treatment of childhood perennial allergic rhinitis. ( Hsieh, JC; Lai, DS; Lee, HS; Lin, KL; Lue, KH, 2002) |
| "Our objective was to test the hypothesis that cetirizine would be as safe as placebo for long-term use in this population." | 2.69 | Prospective, long-term safety evaluation of the H1-receptor antagonist cetirizine in very young children with atopic dermatitis. ETAC Study Group. Early Treatment of the Atopic Child. ( Simons, FE, 1999) |
| " However, systemic agents that are safe for long-term use are required for patients with widespread or resistant lesions." | 1.51 | Eosinophilic pustular folliculitis of infancy suppressed with cetirizine. ( Demirsoy, U; Kiran, R; Odyakmaz Demirsoy, E; Ozod, U, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (35.00) | 18.2507 |
| 2000's | 8 (40.00) | 29.6817 |
| 2010's | 4 (20.00) | 24.3611 |
| 2020's | 1 (5.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vargas-Mora, P | 1 |
| Arceu, M | 1 |
| Cortés, A | 1 |
| Carreño, L | 1 |
| Odyakmaz Demirsoy, E | 1 |
| Demirsoy, U | 1 |
| Ozod, U | 1 |
| Kiran, R | 1 |
| Gallard, C | 1 |
| Law-Ping-Man, S | 1 |
| Darrieux, L | 1 |
| Tisseau, L | 1 |
| Safa, G | 1 |
| Knight, E | 1 |
| Fischer, P | 1 |
| Arndt, C | 1 |
| Anim, S | 1 |
| Joshi, A | 1 |
| Czeschik, JC | 1 |
| Huptas, L | 1 |
| Schadendorf, D | 1 |
| Hillen, U | 1 |
| Abraham, D | 1 |
| Saltoun, CA | 1 |
| Lai, DS | 1 |
| Lue, KH | 1 |
| Hsieh, JC | 1 |
| Lin, KL | 1 |
| Lee, HS | 1 |
| Shimizu, T | 1 |
| Nishihira, J | 1 |
| Watanabe, H | 1 |
| Abe, R | 1 |
| Ishibashi, T | 1 |
| Shimizu, H | 1 |
| Minami, K | 1 |
| Fujii, Y | 1 |
| Kamei, C | 1 |
| Green, WH | 1 |
| Yosipovitch, G | 1 |
| Pichardo, RO | 1 |
| Lee, MW | 1 |
| Nixon, RL | 1 |
| Jacyk, WK | 1 |
| Simson, IW | 1 |
| Slater, DN | 1 |
| Leiferman, KM | 1 |
| Rolland, Y | 1 |
| Mazières, B | 1 |
| Behar, M | 1 |
| Kahn, MF | 1 |
| Cantagrel, A | 1 |
| Laroche, M | 1 |
| Aroni, K | 1 |
| Aivaliotis, M | 1 |
| Liossi, A | 1 |
| Davaris, P | 1 |
| Simons, FE | 1 |
| Musoh, K | 2 |
| Maeda, Y | 1 |
| Tanaka, H | 1 |
| Inagaki, N | 1 |
| Nagai, H | 2 |
| Yadav, TP | 1 |
| Singh, R | 1 |
| Yadav, R | 1 |
| Bhardwaj, M | 1 |
| Satyanarayana, L | 1 |
| Nakamura, N | 1 |
| Harris, DW | 1 |
| Ostlere, L | 1 |
| Buckley, C | 1 |
| Johnson, M | 1 |
| Rustin, MH | 1 |
| Martins, MA | 1 |
| Pasquale, CP | 1 |
| e Silva, PM | 1 |
| Pires, AL | 1 |
| Ruffié, C | 1 |
| Rihoux, JP | 1 |
| Cordeiro, RS | 1 |
| Vargaftig, BB | 1 |
3 trials available for cetirizine and Eosinophilia
| Article | Year |
|---|---|
The comparison of the efficacy and safety of cetirizine, oxatomide, ketotifen, and a placebo for the treatment of childhood perennial allergic rhinitis.
Topics: Allergens; Animals; Anti-Allergic Agents; Blood Proteins; Cetirizine; Child; Conjunctivitis, Allergi | 2002 |
Prospective, long-term safety evaluation of the H1-receptor antagonist cetirizine in very young children with atopic dermatitis. ETAC Study Group. Early Treatment of the Atopic Child.
Topics: Cetirizine; Child, Preschool; Dermatitis, Atopic; Double-Blind Method; Electrocardiography; Eosinoph | 1999 |
Role of cetirizine in treatment of eosinophilia.
Topics: Cetirizine; Child; Child, Preschool; Double-Blind Method; Eosinophilia; Female; Histamine H1 Antagon | 2000 |
17 other studies available for cetirizine and Eosinophilia
| Article | Year |
|---|---|
Multiple annular plaques in an adult woman.
Topics: Cetirizine; Dapsone; Eosinophilia; Erythema; Female; Humans; Hydroxychloroquine; Middle Aged; Predni | 2020 |
Eosinophilic pustular folliculitis of infancy suppressed with cetirizine.
Topics: Anti-Allergic Agents; Cetirizine; Child, Preschool; Eosinophilia; Folliculitis; Humans; Male; Skin D | 2019 |
[Wells syndrome mimicking facial cellulitis: Three cases].
Topics: Adult; Antipruritics; Bacterial Infections; Cellulitis; Cetirizine; Diagnosis, Differential; Drug Th | 2017 |
Cetirizine-responsive, persistent idiopathic eosinophilia in a nonatopic child.
Topics: Anti-Allergic Agents; Cetirizine; Child, Preschool; Eosinophilia; Humans; Hypersensitivity, Immediat | 2017 |
Nodular scabies: hypersensitivity reaction or infection?
Topics: Administration, Oral; Administration, Topical; Animals; Anti-Allergic Agents; Antiparasitic Agents; | 2011 |
Facial swelling and eosinophilia in a 44-year-old woman.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Angioedema; Cefuroxime; Cetirizine; Diagnosis, Diffe | 2002 |
Cetirizine, an H1-receptor antagonist, suppresses the expression of macrophage migration inhibitory factor: its potential anti-inflammatory action.
Topics: Allergens; Ambrosia; Animals; Anti-Inflammatory Agents; Cell Line; Cetirizine; Chemokine CCL11; Chem | 2004 |
Participation of chemical mediators in the development of experimental allergic conjunctivitis in rats.
Topics: Administration, Oral; Animals; Carbazoles; Cetirizine; Conjunctivitis, Allergic; Disease Models, Ani | 2004 |
Recurrent, pruritic dermal plaques and bullae. Diagnosis: eosinophilic cellulitis (Wells syndrome).
Topics: Administration, Oral; Aged, 80 and over; Anti-Allergic Agents; Anti-Inflammatory Agents; Blister; Ce | 2007 |
Eosinophilic cellulitis case report: treatment options.
Topics: Administration, Oral; Cellulitis; Cetirizine; Cyproheptadine; Dapsone; Drug Therapy, Combination; Eo | 1994 |
Pachydermatous eosinophilic dermatitis.
Topics: Adolescent; Anti-Inflammatory Agents; Cetirizine; Child; Dapsone; Dermatitis; Drug Therapy, Combinat | 1996 |
Does the atopic ("allergic") rheumatism of NERDS really exist? Report of a case.
Topics: Adult; Cetirizine; Cimetidine; Dermatitis; Diagnosis, Differential; Edema; Eosinophilia; Follow-Up S | 1997 |
Eosinophilic cellulitis in a child successfully treated with cetirizine.
Topics: Anti-Allergic Agents; Cellulitis; Cetirizine; Child; Eosinophilia; Female; Humans; Leg Dermatoses; T | 1999 |
Effect of a novel anti-allergic agent, HSR-609, on antigen-induced airway hyperresponsiveness in mice.
Topics: Acetylcholine; Animals; Anti-Allergic Agents; Anti-Inflammatory Agents; Benzoxepins; Bronchial Hyper | 2000 |
Effects of an amphoteric antiallergic agent, HSR-609, on antigen-induced late phase nasal eosinophilia in brown Norway rats.
Topics: Animals; Anti-Allergic Agents; Anti-Inflammatory Agents; Benzoxepins; Cetirizine; Eosinophilia; Immu | 2000 |
Eosinophilic pustular folliculitis in an HIV-positive man: response to cetirizine.
Topics: Cetirizine; Eosinophilia; Folliculitis; Histamine H1 Antagonists; HIV Seropositivity; Humans; Hydrox | 1992 |
Interference of cetirizine with the late eosinophil accumulation induced by either PAF or compound 48/80.
Topics: Administration, Topical; Animals; Cetirizine; Chemotactic Factors, Eosinophil; Eosinophilia; Histami | 1992 |